title: Exaggerated neurological side-effects of oral and intravesical oxybutynin in a patient with multiple sclerosis.
authors.forename: S
authors.initials: S
authors.lastname: Vaidyanathan
authors.forename: K R
authors.initials: KR
authors.lastname: Krishnan
authors.forename: B M
authors.initials: BM
authors.lastname: Soni
authors.forename: M H
authors.initials: MH
authors.lastname: Fraser
mesh_terms: D000328:Adult; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000150:complications*; D012996:Solutions
chemical_list: D018680:Cholinergic Antagonists; D008333:Mandelic Acids; D012996:Solutions; C005419:oxybutynin